Trump Strikes Drug Pricing Deals
The White House says nine more drugmakers joined Trump's push to lower prescription costs.
0 left6 center9 right
Updated Aug 31, 8:32pm ETBoth sides, every morning
The day’s biggest stories and how each side covered them. Free.
The reporting
President Donald Trump announced deals with nine more drugmakers—Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB—to cut prices under his most-favored-nation initiative. The White House said the additions bring the program to 26 companies covering 89% of the branded drug market. The voluntary agreements target discounted sales to state Medicaid programs and tie U.S. prices to the lowest prices paid in other developed countries. Trump projected more than $600 billion in savings, though drug-by-drug prices and discount terms have not been released.
Analysis & opinion
The commentary is scattered.
weigh in — but each argues its own distinct claim, so no shared angle emerged. The other report the story straight.
Also today
All of today's stories →- 1JD Vance Defends Ramaswamy Attack AdLeft & CenterLeft & Center102articles
- 2Russia Frees Stephen HubbardBalancedBalanced58articles
- 3Balanced58articles
- 4Balanced49articles
- 5OpenAI Finds PHP FlawBalancedBalanced44articles
- 6Meta Ordered To Pay $25BLeft & CenterLeft & Center37articles

